Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England

The Omicron variant of SARS-CoV-2 became the globally dominant variant in early 2022. A sub-lineage of the Omicron variant (BA.2) was identified in England in January 2022. Here, we investigated hospitalisation and mortality risks of COVID-19 cases with the Omicron sub-lineage BA.2 (n = 258,875) com...

Descripción completa

Detalles Bibliográficos
Autores principales: Webster, H. H., Nyberg, T., Sinnathamby, M. A., Aziz, N. Abdul, Ferguson, N., Seghezzo, G., Blomquist, P. B., Bridgen, J., Chand, M., Groves, N., Myers, R., Hope, R., Ashano, E., Lopez-Bernal, J., De Angelis, D., Dabrera, G., Presanis, A. M., Thelwall, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559149/
https://www.ncbi.nlm.nih.gov/pubmed/36229438
http://dx.doi.org/10.1038/s41467-022-33740-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559149/
https://www.ncbi.nlm.nih.gov/pubmed/36229438
http://dx.doi.org/10.1038/s41467-022-33740-9

Ejemplares similares